Pee Safe targets historically underserved women’s health and hygiene needs with a portfolio spanning toilet sanitizers, menstrual and intimate-care products, and general personal-care SKUs. The company’s range is stocked in 50,000 retail outlets across 100 cities and on major e-commerce and quick-commerce platforms. Management reports more than ₹150 crore in annualised net revenue; in FY25 it generated ₹82 crore in operating revenue, a 46 % increase year-on-year, while narrowing its loss to ₹4 crore. Fresh capital will be channelled into widening its offline retail footprint, boosting brand-led marketing, and deepening partnerships on quick-commerce and online marketplaces. Founded with the aim of breaking taboos around women’s hygiene, Pee Safe has built a business the founders describe as “profitable at scale” with disciplined unit economics. The brand intends to use OrbiMed’s healthcare network and new board representation to accelerate its next phase of growth.

Total raised

$40M

Funding rounds

3

Latest round

Series C

Latest activity

Jan 2026